THE MECHANISM OF NANOPARTICLES IN INHIBITING THE ACTIVITY OF SELF-ATTACKING IMMUNE CELLS

Abstract

Autoimmunity is a condition in which the immune system attacks the body's own tissues, resulting in various diseases and complications. Conventional treatments are generally used, but they often have significant side effects and are not sufficiently specific in their mechanisms of action. In this study, the authors are interested in understanding how nanoparticles can be used to inhibit the activity of immune cells that attack the body itself. Nanoparticles can be designed to specifically target certain immune cells, deliver drugs directly to their targets, and help regulate immune responses so that they do not become excessive. By modifying their surfaces and selecting appropriate materials, nanoparticles can help reduce the activity of autoreactive T cells, decrease the production of inflammatory cytokines, and restore immune-system balance. Initial testing has shown that the use of nanoparticles can reduce inflammation and tissue damage in autoimmune models. This approach has the potential to become a safer and more targeted therapy compared with existing treatments. These findings indicate that nanoparticles may play an important role in controlling autoimmunity and open opportunities for the development of more effective and specific immune therapies in the future.